Entity Details

Primary name IL1RA_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP18510
EntryNameIL1RA_HUMAN
FullNameInterleukin-1 receptor antagonist protein
TaxID9606
Evidenceevidence at protein level
Length177
SequenceStatuscomplete
DateCreated1990-11-01
DateModified2021-06-02

Ontological Relatives

GenesIL1RN

GO terms

Show/Hide Table
GOName
GO:0002437 inflammatory response to antigenic stimulus
GO:0005125 cytokine activity
GO:0005149 interleukin-1 receptor binding
GO:0005150 interleukin-1, type I receptor binding
GO:0005151 interleukin-1, type II receptor binding
GO:0005152 interleukin-1 receptor antagonist activity
GO:0005615 extracellular space
GO:0005737 cytoplasm
GO:0005886 plasma membrane
GO:0006629 lipid metabolic process
GO:0006953 acute-phase response
GO:0006954 inflammatory response
GO:0006955 immune response
GO:0019221 cytokine-mediated signaling pathway
GO:0030073 insulin secretion
GO:0034115 negative regulation of heterotypic cell-cell adhesion
GO:0045352 interleukin-1 type I receptor antagonist activity
GO:0045353 interleukin-1 type II receptor antagonist activity
GO:0051384 response to glucocorticoid
GO:0070062 extracellular exosome
GO:0070498 interleukin-1-mediated signaling pathway
GO:2000660 negative regulation of interleukin-1-mediated signaling pathway

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm
Secreted

Domains

Show/Hide Table
DomainNameCategoryType
IPR000975 Interleukin-1 familyFamilyFamily
IPR003297 Interleukin-1 receptor antagonist/Interleukin-36FamilyFamily
IPR008996 Cytokine IL1/FGFFamilyHomologous superfamily
IPR020877 Interleukin-1 conserved siteSiteConserved site
IPR039348 Interleukin-1 receptor antagonistFamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
612852 OMIMInterleukin 1 receptor antagonist deficiency (DIRA)A rare autoinflammatory disease of skin and bone resulting in sterile multifocal osteomyelitis, periostitis, and pustulosis from birth. The term autoinflammatory disease describes a group of disorders characterized by attacks of seemingly unprovoked inflammation without significant levels of autoantibodies and autoreactive T-cells. The disease is caused by variants affecting the gene represented in this entry.
612628 OMIMMicrovascular complications of diabetes 4 (MVCD4)Pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new-onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis. Disease susceptibility is associated with variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB06372 RilonaceptDrugbankbiotech